XML 56 R41.htm IDEA: XBRL DOCUMENT v3.25.2
REVENUE - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Disaggregation of Revenue [Line Items]        
Revenue recognized $ 811,085 $ 699,264 $ 1,517,870 $ 1,336,788
Screening        
Disaggregation of Revenue [Line Items]        
Revenue recognized 628,481 531,606 1,168,488 1,006,404
Screening | Medicare Parts B & C        
Disaggregation of Revenue [Line Items]        
Revenue recognized 226,888 195,337 428,570 369,127
Screening | Commercial        
Disaggregation of Revenue [Line Items]        
Revenue recognized 339,465 283,729 623,698 537,872
Screening | Other        
Disaggregation of Revenue [Line Items]        
Revenue recognized 62,128 52,540 116,220 99,405
Precision Oncology        
Disaggregation of Revenue [Line Items]        
Revenue recognized 182,604 167,658 349,382 330,384
Precision Oncology | Medicare Parts B & C        
Disaggregation of Revenue [Line Items]        
Revenue recognized 47,601 47,467 93,808 95,517
Precision Oncology | Commercial        
Disaggregation of Revenue [Line Items]        
Revenue recognized 48,033 49,187 96,303 95,887
Precision Oncology | International        
Disaggregation of Revenue [Line Items]        
Revenue recognized 55,256 46,722 106,843 91,255
Precision Oncology | Other        
Disaggregation of Revenue [Line Items]        
Revenue recognized $ 31,714 $ 24,282 $ 52,428 $ 47,725